Abstract
Objective: Chemotherapy may lead to HBV re-activation. The aim of this study is to evaluate screening results for HBV infection before chemotherapy, treatment status in patients who are being followed up and planned to receive chemotherapy in our hospital. Patients and Methods: A total of 83 patients who were admitted to Medical Oncology Outpatient Clinic of S.B.U. Kanuni Sultan Suleyman Research and Training Hospital between June 2015 and January 2018 and planned to receive chemotherapy were included in the study. Age, diagnoses, HBsAg, anti-HBs, anti-HBc, and HBV-DNA results of the patients were recorded through screening files. Results: When a total of 83 patients who were planned to receive chemotherapy were analyzed with regard to cancer type; breast and ovarian cancers were found to be the most common. HBsAg positivity ratio of our patients was 3.6%, anti-HBs positivity was fund as 38.6%. Ratio of the patients whose anti-HBc was positive when HbsAg, anti-HBs negative was 7.2% (6/83) and HBV-DNA positivity was found in no of these patients. Conclusion: In conclusion, patients should be screened for HBV infection considering risk factors like reactivation, hepatic failure, interruption of chemotherapy; we consider that conducting further studies with larger series would be important.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Clinical and Experimental Investigations
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
